Automatic Web Traffic Generator

Keytruda Extends OS in Advanced Esophageal Cancer

SAN FRANCISCO -- Pembrolizumab (Keytruda) significantly improved overall survival compared with chemotherapy when used as a second-line treatment for patients with advanced esophageal cancer whose tum... read more

Dr. Molena on Challenges With Endoscopic Resection in Esophageal Cancers

Daniela Molena, MD, director, Esophageal Surgery Program, Memorial Sloan Kettering Cancer Center, discusses what she believes is the Achilles heel of endoscopic resection in patients with esophageal c... read more

A New Standard of Care for Some Advanced Esophageal Cancer Patients

Pembrolizumab offers significantly improved overall survival as a second-line therapy for patients with metastatic esophageal cancer and high PD-L1 expression compared with chemotherapy, according to ... read more

Merck’s Keytruda Cuts Death Risk by 31 Percent in Esophageal Cancer

Merck’s Keytruda just keeps on proving its value to the company and patients. The company released data from KEYNOTE-181, a Phase III trial of Keytruda as a monotherapy for the second-line treatment o... read more

Fewer complications found with hybrid surgery for esophageal cancer

(HealthDay)—Hybrid minimally invasive esophagectomy results in lower incidence of intraoperative and postoperative major complications compared with open esophagectomy for esophageal cancer ... read more

Keytruda cuts risk of death by 31% in esophageal cancer trial

MSD’s Keytruda has cut the risk of death by 31% in patients with esophageal or esophagogastric junction carcinoma or adenocarcinoma who progressed after standard therapy. The results, from the ... read more

Bruce Corbitt Enters Hospice Care, Vows Never To Stop Fighting Cancer

Local metal legend Bruce Corbitt has entered hospice care. The former lead signer of Rigor Mortis and Warbeast, the 56-year-old Corbitt has been battling stage 4 esophageal cancer since early 2018. He ... read more

Strange Swirling Patterns Across Kansas Woman's Body Was Rare Symptom of Anal Cancer

“She received a clinical diagnosis of erythema gyratum repens, a rare paraneoplastic rash usually associated with breast, lung, or esophageal cancer,” the case report said. She was treated with steroi... read more

Pembrolizumab Shows OS Benefit in PD-L1+ Esophageal Cancer

Pembrolizumab (Keytruda) was found to reduce the risk of death by 31% in patients with PD-L1–positive (combined positive score [CPS] ≥10) advanced or metastatic esophageal or esophageal junction carci... read more

Merck's Keytruda slashes death risk by 31% in esophageal cancer win

Back in November, Merck said its immuno-oncology star, Keytruda, had topped chemo at lengthening the lives of some esophageal cancer patients. Monday, it showed that the win was a sizable one. The dru... read more

A Win for Adjuvant Anti-PD-1 Drug in Esophageal Ca

"It is definitely encouraging. We have not seen the [survival] curves flattening out like this in esophageal cancer for a very long time, but we need to wait for randomized data." The standard approac... read more